Humulus kriya. The applicant listed for this patent is Bomi, LLC. S. patent application num...

Humulus kriya. The applicant listed for this patent is Bomi, LLC. S. patent application number 15/932529 was filed with the patent office on 2019-09-12 for humulus yunnanensis plant named 'kriya'. The leaves of this new humulus plant contain a cannabinoid level of ˜15-23 mg/g and the inflorescence of this new humulus plant contain a . The leaves of this new humulus plant contain a cannabinoid level of ~ 15-23 mg / g and the inflorescence of this new humulus plant contain a CBD regulatory compliance, Independent laboratory verification of Kriya® Hops CBD, including botanical identification as Humulus species, cannabinoid analysis confirming CBD presence, and no This new variety of high cannabinoid content plant was named Humulus yunnanensis var kriya or ‘ Kriya’. Invention is A new humulus plant named ‘ Kriya ’ is disclosed. ImmunAg LLP grows Humulus kriya and manufactures ImmunAg ™. Further propagation of female ‘ Kriya ’ was carried out using in-vitro culture starting U. A new humulus plant named “ Kriya ' is disclosed . Peak Health Center is the exclusive distributor of ImmunAg ™ in USA. The leaves of this new humulus plant contain a cannabinoid level of ˜15-23 mg/g and the inflorescence of this new humulus plant contain a ImmunAg™ is Humulus CBD oil extracted from the patented Kriya® Hops plant (US Patent # PP31,477 P3). ImmunAG™ is a combination of β-Caryophyllene, CBD and ⍺-Humulene. A new humulus plant named ‘Kriya’ is disclosed. ‘Kriya’ is distinguishable from its originating parents and other related varieties of Humulus yunnanensis based on the cannabinoid content in its leaves and inflorescence. cyfhue rjko ymwld etbj bqnev wfje guuod efmdq sgmy pysu